Address
Form of workJob Description
JOB DESCRIPTION
#DareToDoMore
How will you make an impact?
The Corneal Regional Business Manager will be part of Glaukos' Commercial Team and will provide coverage and support in the Pacific Northwest territory. This individual will report to the Area Director and collaborate with Glaucoma Regional Business Managers' counterparts to achieve commercial objectives.
What will you do?
The Corneal Regional Business Manager responsibilities include developing key growth sales strategies, business development tactics and action plans. Successful execution of these strategies is required to achieve the financial targets. The Corneal Regional Business Manager duties will include hitting annual equipment & procedural targets, building relationships and understanding customer trends driving results while adhering to the company's values of integrity, mutual respect, accountability and commitment to quality.
Other responsibilities will encompass:
These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family.
Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others.
We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class! Moreover, Glaukos Corporation has been Certified as a Great Place to Work the last two years!
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
ABOUT US
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device-the iStent®-in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.
In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for glaucoma, corneal health, and retinal diseases.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol "GKOS". Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, sex including sexual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.
#DareToDoMore
How will you make an impact?
The Corneal Regional Business Manager will be part of Glaukos' Commercial Team and will provide coverage and support in the Pacific Northwest territory. This individual will report to the Area Director and collaborate with Glaucoma Regional Business Managers' counterparts to achieve commercial objectives.
What will you do?
The Corneal Regional Business Manager responsibilities include developing key growth sales strategies, business development tactics and action plans. Successful execution of these strategies is required to achieve the financial targets. The Corneal Regional Business Manager duties will include hitting annual equipment & procedural targets, building relationships and understanding customer trends driving results while adhering to the company's values of integrity, mutual respect, accountability and commitment to quality.
Other responsibilities will encompass:
- Collaborate, partner & lead local sales representatives, field reimbursement, marketing, field service and clinical support to ensure commercial success
- Effectively communicate the business value proposition and financial feasibility for capital equipment sales process through proposals/presentation at physician, executive, administrator level
- Interact with Marketing Director/Optometric outreach, administrators and develop CXL marketing strategy, deploy resources and drive OD education
- Identify OD and MD referral opportunities around CXL centers and influence referral patterns
- Engage, educate, and motivate staff from technicians to billing department on clinical workflow and support procedures
- Cohesively work, communicate with the Glaukos RBM peers and other Glaukos departments
- Bachelor's degree, concentration in Business or Marketing preferred
- Minimum 3 years Ophthalmic Medical Device, Surgical Device or pharmaceutical sales experience
- 5-10 years proven track record in sales performance in the medical device industry
- Proven sales executive experience, meeting or exceeding targets
- Previous experience as a sales executive, sales manager or sales & marketing manager
- Proven ability to articulate the distinct value of products, procedures and services against other competitive and non-competitive products
- Ability to travel 2-3 nights per week and manage multi-state geography
These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family.
Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others.
We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class! Moreover, Glaukos Corporation has been Certified as a Great Place to Work the last two years!
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
ABOUT US
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device-the iStent®-in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.
In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for glaucoma, corneal health, and retinal diseases.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol "GKOS". Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, sex including sexual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.
